Arcturus Therapeutics
ARCT
ARCT
130 hedge funds and large institutions have $578M invested in Arcturus Therapeutics in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 43 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less funds holding
Funds holding: 139 → 130 (-9)
21% less capital invested
Capital invested by funds: $736M → $578M (-$158M)
33% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 24
Holders
130
Holding in Top 10
1
Calls
$16.6M
Puts
$7.64M
Top Buyers
| 1 | +$31.3M | |
| 2 | +$11.5M | |
| 3 | +$3.85M | |
| 4 |
Morgan Stanley
New York
|
+$3.84M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.78M |
Top Sellers
| 1 | -$6.1M | |
| 2 | -$4.75M | |
| 3 | -$2.39M | |
| 4 |
Citigroup
New York
|
-$2.25M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.9M |